معرفی
Chris Bailey is a Reader (equivalent to Associate Professor) in the Department of Life Sciences at the University of Bath, where he leads research in the Centre for Therapeutic Innovation. His laboratory focuses on understanding the neuronal changes caused by drugs of abuse, with particular emphasis on opioid tolerance and addiction mechanisms. He currently serves as Principal Investigator on multiple active research projects funded by the Medical Research Council and Biotechnology and Biological Sciences Research Council.
Research Focus
Dr. Bailey's primary research investigates the molecular mechanisms underlying opiate tolerance, specifically examining how prolonged opioid administration leads to receptor desensitization and internalization at the µ-opioid receptor. His groundbreaking work has demonstrated that different ligands at this receptor can trigger desensitization through entirely distinct intracellular signaling pathways. Current research directions include elucidating the precise relationship between receptor desensitization and behavioral tolerance, as well as investigating synaptic plasticity changes in key brain regions associated with addiction (ventral tegmental area, nucleus accumbens, and prefrontal cortex).
His laboratory employs sophisticated methodologies including electrophysiological recordings, real-time cell imaging, and comprehensive behavioral assessments of reward, analgesia, and respiratory depression. Recent work has expanded into understanding the dangerous interactions between benzodiazepines and opioids that contribute to overdose deaths, with the goal of developing evidence-based harm reduction strategies.
Research Impact
Analysis of Dr. Bailey's recent publication record reveals a strong focus on translational opioid pharmacology, with particular emphasis on receptor signaling mechanisms, overdose prevention, and sex-specific responses to opioid drugs. His work increasingly addresses the public health crisis of opioid overdose through studies examining benzodiazepine-opioid interactions and developing novel harm reduction approaches. The research shows growing interdisciplinary collaboration between neuroscience, pharmacology, and public health domains.
Research Projects
- Functional roles of presynaptic opioid receptors (2022-2026)
- Opioid overdose deaths: Understanding lethal benzodiazepine-opioid interactions (2022-2026)
- Buvidal and kappa opioid receptor blockade (2021-2022)
- New tools for acute spatiotemporal control of GPCR signalling in vivo (2020-2023)
Academic Contributions
Dr. Bailey actively supervises doctoral students and has completed supervision of 13 research students. His work contributes to UN Sustainable Development Goal 3 (Good Health and Well-being) through research on addiction mechanisms and overdose prevention. He collaborates extensively with researchers including Sambrook, Williams, and Husbands, and his research has been cited over 50 times in the past two years according to available metrics.
